Research graph
References from Fitness costs and benefits in response to artificial artesunate selection in Plasmodium. Local targets link to admitted publications; unresolved targets remain external evidence.
Seasonal fluctuation of drug-resistant malaria parasites: a sign of fitness cost
10.1016/j.pt.2009.05.006 · 2009 · External reference
Persistence of pyrimethamine resistance in the exoerythrocytic stages of Plasmodium gallinaceum
10.1016/0014-4894(67)90034-3 · 1967 · External reference
10.1515/9781400840908
10.1515/9781400840908 · 2008 · External reference
Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13
10.1038/s41598-019-47034-6 · 2019 · External reference
10.1002/9780470515075
10.1002/9780470515075 · 2007 · External reference
Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections
10.1186/1475-2875-3-33 · 2004 · External reference
Virulence and competitive ability in genetically diverse malaria infections
10.1073/pnas.0500078102 · 2005 · External reference
Artemisinin Resistance in Plasmodium falciparum Malaria
10.1056/nejmoa0808859 · 2009 · External reference
Understanding artemisinin-resistant malaria
10.1097/qco.0000000000000199 · 2015 · External reference
Mixed lethal strains of Plasmodium gallinaceum: Drug-sensitive, transferable (SP) × drug-resistant, non-transferable (BI)
10.1016/0014-4894(56)90020-0 · 1956 · External reference
The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance
10.1016/j.drup.2005.03.003 · 2005 · External reference
Bird Malaria
1940 · External reference
Fitness of artemisinin-resistant Plasmodium falciparum in vitro
10.1093/jac/dkv199 · 2015 · External reference
Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites
10.1111/j.1558-5646.2010.01068.x · 2010 · External reference
The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection
10.1111/j.1420-9101.2011.02369.x · 2011 · External reference
Costs and Benefits of Resistance against Antimalarial Drugs
10.1016/s0169-4758(98)01297-6 · 1998 · External reference
Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies
10.1016/j.drup.2004.08.003 · 2004 · External reference
Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance
10.7554/elife.51015 · 2020 · External reference
Antimalarial Drug Resistance: A Threat to Malaria Elimination
10.1101/cshperspect.a025619 · 2017 · External reference
Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance
10.1126/science.1260403 · 2015 · External reference
Fitness Costs and the Rapid Spread of kelch13-C580Y Substitutions Conferring Artemisinin Resistance
10.1128/aac.00605-18 · 2018 · External reference
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
10.3390/molecules15031705 · 2010 · External reference
Seasonal Carriage of pfcrt and pfmdr1 Alleles in Gambian Plasmodium falciparum Imply Reduced Fitness of Chloroquine‐Resistant Parasites
10.1086/522154 · 2007 · External reference
Rapid Response to Selection, Competitive Release and Increased Transmission Potential of Artesunate-Selected Plasmodium chabaudi Malaria Parasites
10.1371/journal.ppat.1004019 · 2014 · External reference
Evolutionary biology and the avoidance of antimicrobial resistance
10.1111/j.1752-4571.2008.00066.x · 2009 · External reference
Evolutionary Ecology of Avian Malaria: Past to Present
10.1016/j.pt.2018.06.002 · 2018 · External reference
Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase
10.1073/pnas.94.4.1124 · 1997 · External reference
Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa
10.1038/ncomms9614 · 2015 · External reference
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
10.1126/science.1260867 · 2014 · External reference
Pairwise growth competitions identify relative fitness relationships among artemisinin resistant Plasmodium falciparum field isolates
10.1186/s12936-019-2934-4 · 2019 · External reference
Loss of malarial susceptibility to artemisinin in Thailand
10.1016/s0140-6736(12)60488-7 · 2012 · External reference
Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
10.1038/s41591-020-1005-2 · 2020 · External reference
Fitness of drug-resistant malaria parasites
10.1016/j.actatropica.2005.04.005 · 2005 · External reference
Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model
10.1073/pnas.0707766104 · 2007 · External reference
10.30875/6c551ba0-en
10.30875/6c551ba0-en · 2021 · External reference
Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia
10.1128/aac.01868-12 · 2013 · External reference
Wolbachia increases susceptibility to Plasmodium infection in a natural system
10.1098/rspb.2013.2837 · 2014 · External reference
